Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 7, 2006 - Issue 10
Submit an article Journal homepage
344
Views
23
CrossRef citations to date
0
Altmetric
Drug Evaluation

Everolimus: an immunosuppressive agent in transplantation

Jignesh K Patel Assistant Clinical Professor of Medicine/Cardiology, The David Geffen School of Medicine at UCLA, Division of Cardiology, UCLA Medical Center, 100 Medical Plaza Building, #630, Los Angeles, California 90095-6988, USA; Associate Medical Director, UCLA Heart Transplant Program, USA
&
Jon A Kobashigawa Clinical Professor of Medicine/Cardiology, Chief of the Division of Clinical Faculty Medicine, The David Geffen School of Medicine at UCLA, Division of Cardiology, UCLA Medical Center, 100 Medical Plaza Building, #630, Los Angeles, California 90095-6988, USA. [email protected]; Medical Director, UCLA Heart Transplant Program, USA
Pages 1347-1355 | Published online: 29 Jun 2006

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Helio Tedesco-Silva Jr, Claudia Rosso Felipe, Tainá Veras de Sandes Freitas, Marina Pontello Cristeli, Carolina Araújo Rodrigues & José Osmar Medina Pestana. (2011) Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation. Transplant Research and Risk Management 3, pages 9-29.
Read now
S Allan Schaffer & Heather J Ross. (2010) Everolimus: efficacy and safety in cardiac transplantation. Expert Opinion on Drug Safety 9:5, pages 843-854.
Read now

Articles from other publishers (21)

Bo Chen, Hongshu Zhou, Xiaoxi Zhou, Liting Yang, Yuanyuan Xiong & Liyang Zhang. (2022) Comprehensive Analysis of Endoplasmic Reticulum Stress in Intracranial Aneurysm. Frontiers in Cellular Neuroscience 16.
Crossref
Ahmet Gurakar, Burcak E Tasdogan, Cem Simsek, Michelle Ma & Behnam Saberi. (2017) Update on Immunosuppression in Liver Transplantation. Euroasian Journal of Hepato-Gastroenterology 9:2, pages 96-101.
Crossref
Ami Raval, Pratap Bahadur & Ankur Raval. (2018) Effect of nonionic surfactants in release media on accelerated in-vitro release profile of sirolimus eluting stents with biodegradable polymeric coating. Journal of Pharmaceutical Analysis 8:1, pages 45-54.
Crossref
Nicolas Pallet, Ana A. Fernández-Ramos & Marie-Anne Loriot. 2018. Biology of T Cells - Part A. Biology of T Cells - Part A 169 200 .
Laurent Laborde, Fatos Oz, Mitko Ristov, Daniel Guthy, Dario Sterker & Paul McSheehy. (2017) Continuous low plasma concentrations of everolimus provides equivalent efficacy to oral daily dosing in mouse xenograft models of human cancer. Cancer Chemotherapy and Pharmacology 80:4, pages 869-878.
Crossref
Filipe Palavra, Conceição Robalo & Flávio Reis. (2017) Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis Complex. Oxidative Medicine and Cellular Longevity 2017, pages 1-11.
Crossref
Ana A. Fernández-Ramos, Virginie Poindessous, Catherine Marchetti-Laurent, Nicolas Pallet & Marie-Anne Loriot. (2016) The effect of immunosuppressive molecules on T-cell metabolic reprogramming. Biochimie 127, pages 23-36.
Crossref
Volker Schmidt, Tino Prell, Anne Treschl, Anne Klink, Andreas Hochhaus & Herbert G. Sayer. (2016) Clinical Management of Posterior Reversible Encephalopathy Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Series and Review of the Literature. Acta Haematologica 135:1, pages 1-10.
Crossref
. Experimental and Clinical Transplantation 12:3.
Crossref
Bo Tang, Xuesong Dong, Zheng Wei, Haiquan Qiao, Hongchi Jiang, Bing Liu & Xueying Sun. (2014) Enhanced Autophagy by Everolimus Contributes to the Antirestenotic Mechanisms in Vascular Smooth Muscle Cells. Journal of Vascular Research 51:4, pages 259-268.
Crossref
Carlos Bujalance-Cabrera, José Manuel Vaquero-Barrios, Javier Redel-Montero, Laura Caballero-Ballesteros, Antonio Requejo-Jiménez & Francisco Santos-Luna. (2012) Reducción de tamaño del angiomiolipoma renal tras el tratamiento con everolimus en trasplante pulmonar por linfangioleiomiomatosis. Archivos de Bronconeumología 48:12, pages 479-481.
Crossref
Carlos Bujalance-Cabrera, José Manuel Vaquero-Barrios, Javier Redel-Montero, Laura Caballero-Ballesteros, Antonio Requejo-Jiménez & Francisco Santos-Luna. (2012) Reduction in Size of Renal Angiomyolipoma After Treatment With Everolimus in Lung Transplantation Due to Lymphangioleiomyomatosis. Archivos de Bronconeumología (English Edition) 48:12, pages 479-481.
Crossref
Robert P Baughman, Keith C Meyer, Ian Nathanson, Luis Angel, Sangeeta M Bhorade, Kevin M Chan, Daniel Culver, Christopher G Harrod, Mary S Hayney, Kristen B Highland, Andrew H Limper, Herbert Patrick, Charlie Strange & Timothy Whelan. (2012) Monitoring of Nonsteroidal Immunosuppressive Drugs in Patients With Lung Disease and Lung Transplant Recipients. Chest 142:5, pages e1S-e111S.
Crossref
Mark C. Lavigne, Jessica L. Grimsby & Michael J. Eppihimer. (2012) Antirestenotic Mechanisms of Everolimus on Human Coronary Artery Smooth Muscle Cells. Journal of Cardiovascular Pharmacology 59:2, pages 165-174.
Crossref
M.T. Parada, A. Alba, C. Sepúlveda & J. Melo. (2011) Long-Term Use of Everolimus in Lung Transplant Patients. Transplantation Proceedings 43:6, pages 2313-2315.
Crossref
Victor M. Rivera, Rachel M. Squillace, David Miller, Lori Berk, Scott D. Wardwell, Yaoyu Ning, Roy Pollock, Narayana I. Narasimhan, John D. Iuliucci, Frank Wang & Tim Clackson. (2011) Ridaforolimus (AP23573; MK-8669), a Potent mTOR Inhibitor, Has Broad Antitumor Activity and Can Be Optimally Administered Using Intermittent Dosing Regimens. Molecular Cancer Therapeutics 10:6, pages 1059-1071.
Crossref
Marika Kamberi, Sushma Nayak, Kathy Myo-Min, Troy P. Carter, Leonard Hancock & Debra Feder. (2009) A novel accelerated in vitro release method for biodegradable coating of drug eluting stents: Insight to the drug release mechanisms. European Journal of Pharmaceutical Sciences 37:3-4, pages 217-222.
Crossref
Davide Mineo, Junichiro Sageshima, George W. Burke & Camillo Ricordi. (2009) Minimization and withdrawal of steroids in pancreas and islet transplantation. Transplant International 22:1, pages 20-37.
Crossref
Felix Braun, Freya A. Goumas, Dieter C. Broering & Matthias Behrend. 2009. 619 646 .
Savitha Subramanian & Dace L. Trence. (2007) Immunosuppressive Agents: Effects on Glucose and Lipid Metabolism. Endocrinology and Metabolism Clinics of North America 36:4, pages 891-905.
Crossref
Ming Wu, Patricia R. Wahl, Michel Le Hir, Ying Wäckerle-Men, Rudolf P. Wüthrich & Andreas L. Serra. (2007) Everolimus Retards Cyst Growth and Preserves Kidney Function in a Rodent Model for Polycystic Kidney Disease. Kidney and Blood Pressure Research 30:4, pages 253-259.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.